USFDA finds new manufacturing lapses at Eli Lilly plant: Report Ruchika Sharma21 Jan 2024 4:00 PM ISTU.S. inspectors recently uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by federal investigators, according...
Lilly launches end to end digital healthcare experience through LillyDirect Ruchika Sharma6 Jan 2024 2:16 PM ISTIndianapolis: Eli Lilly and Company has announced LillyDirect, a new digital healthcare experience for patients in the U.S. living with...
USFDA approvals bounce back in 2023, sparking hopes of biotech recovery Ruchika Sharma3 Jan 2024 3:22 PM ISTThe U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an...
Eli Lilly extends tender offer to acquire POINT Biopharma to 15 Dec Ruchika Sharma5 Dec 2023 2:45 PM ISTIndianapolis: Eli Lilly and Company has announced the extension of the expiration of the tender offer to acquire all of the issued and...
Eli Lilly secures USFDA nod for leukemia treatment Jaypirca Ruchika Sharma2 Dec 2023 1:30 PM ISTThis is the second FDA-approved indication for Jaypirca following the January 2023 Accelerated Approval for the treatment of adult patients with...
Teva Pharma drops migraine drug patent case against Eli Lilly Ruchika Sharma29 Nov 2023 1:30 PM ISTUnited States: Israel-based drugmaker Teva Pharmaceuticals has agreed to end a patent lawsuit over Eli Lilly's migraine drug Emgality...
Eli Lilly Zepbound Injection for Weight Loss gets USFDA okay Roshni Dhar14 Nov 2023 3:54 PM ISTEli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Zepbound (tirzepatide) injection, an...
Health Bulletin 11/November/2023 Roshni Dhar11 Nov 2023 2:16 PM ISTHere are the top health stories for the day:NBE grants final opportunity for registration to 2021, 2022 batch traineesThe National Board of...
Eli Lilly bags USFDA nod for Zepbound injection for weight loss Ruchika Sharma9 Nov 2023 1:30 PM ISTZepbound should be used with a reduced-calorie diet and increased physical activity.
Novo Nordisk, Eli Lilly see insatiable demand for weight loss drugs Ruchika Sharma5 Nov 2023 10:00 AM ISTNovo Nordisk and Eli Lilly both expect juggernaut sales for their diabetes and weight-loss drugs to extend into coming years - limited only by...
Eli Lilly gets CDSCO Panel Nod To study antidiabetic drug Orforglipron Dr. Divya Colin28 Oct 2023 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Maintenance dose of lebrikizumab may clear skin and improve symptoms in atopic dermatitis Dr. Kamal Kant Kohli28 Oct 2023 10:30 AM ISTResearchers have found in a new trial that Both 2-week and monthly dosing of lebrikizumab achieves skin clearance and symptoms relief in atopic...
